Ghent University Academic Bibliography

1 – 10 of 566

show: 10
|
sort: year (new to old)

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/publication?embed=1&q=affiliation+exact+GE&q=author+exact+801000624089&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

«previous
1
2
3
4
…
56
57
next»

2017
- U
- journalArticle
T-ALL and thymocytes: a message of noncoding RNAs
Annelynn Wallaert UGent, Kaat Durinck UGent, Tom Taghon UGent, Pieter Van Vlierberghe UGent and Franki Speleman UGent (2017) JOURNAL OF HEMATOLOGY & ONCOLOGY. 10. Mark
- U
- journalArticle
Long non-coding RNAs in leukemia: biology and clinical impact
Tim Lammens UGent, Kaat Durinck UGent, Annelynn Wallaert UGent, Franki Speleman UGent and Pieter Van Vlierberghe UGent (2017) Current Opinion Hematology. Mark
- A1
- journalArticle
Targeting tachykinin receptors in neuroblastoma
Anton G Henssen, Andrea Odersky, Annabell Szymansky, Marleen Seiler, Kristina Althoff, Anneleen Beckers, Franki Speleman UGent, Simon Schäfers, Katleen De Preter UGent, Kathy Astrahanseff, et al. (2017) ONCOTARGET. 8(1). p.430-443 Mark
- U
- journalArticle
T-ALL and thymocytes: a message of noncoding RNAs
Annelynn Wallaert UGent, Kaat Durinck UGent, Tom Taghon UGent, Pieter Van Vlierberghe UGent and Franki Speleman UGent (2017) Journal of Hematology and Oncology. 10(1). Mark
- U
- conference
The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma
Liselot Mus UGent, Irina Lambertz, Candy Kumps, Shana Claeys UGent, Geertrui Denecker UGent, Wouter Van Loocke UGent, Christophe Van Neste UGent, Jan Koster, Rogier Versteeg, Nadine Van Roy UGent, et al. (2017) Mark
- C3
- conference
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait
Anneleen Decock UGent, Maté Ongenaert UGent, Bram De Wilde UGent, Bénédicte Brichard, Rosa Noguera, Franki Speleman UGent and Jo Vandesompele UGent (2017) OncoPoint, 5th Research seminar, Abstracts. Mark
- C3
- conference
The TLX1 oncogene modulates the enhancer RNA landscape in T-ALL
Karen Verboom UGent, Kaat Durinck UGent, Matthias De Decker UGent, Wouter Van Loocke UGent, Filip Matthijssens UGent, Jean-Jacques Soulier, Wouter De Laat, Tom Taghon UGent, Pieter Van Vlierberghe UGent and Franki Speleman UGent (2017) Noncoding RNAs : from disease to targeted therapeutics, Abstracts. Mark
- C3
- conference
The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma
Liselot Mus UGent, Irina Lambertz, Candy Kumps, Shana Claeys UGent, Geertrui Denecker UGent, Wouter Van Loocke UGent, Christophe Van Neste UGent, Jan Koster, Rogier Versteeg, Nadine Van Roy UGent, et al. (2017) OncoPoint, 5th Research seminar, Abstracts. Mark
- U
- conference
THE ETV5 ONCOGENE IS A TARGET OF ACTIVATED ALK SIGNALING IN NEUROBLASTOMA
Liselot Mus UGent, Irina Lambertz, Candy Kumps, Shana Claeys UGent, Geertrui Denecker UGent, Wouter Van Loocke UGent, Christophe Van Neste UGent, Jan Koster, Rogier Versteeg, Nadine Van Roy UGent, et al. (2017) Mark
2016
- A1
- journalArticle
Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia
Annelynn Wallaert UGent, Kaat Durinck UGent, Wouter Van Loocke UGent, Inge Van de Walle, Filip Matthijssens UGent, Pieter-Jan Volders UGent, Francisco Avila Cobos UGent, Dries Rombaut UGent, Pieter Rondou UGent, Pieter Mestdagh UGent, et al. (2016) LEUKEMIA. 30(9). p.1927-1930 Mark

«previous
1
2
3
4
…
56
57
next»

your query:: Remove affiliation exact GE; Remove author exact 801000624089